KSSCR 2025 Annual Meeting
2025 Annual Meeting of Korean Society for Stem Cell Research
Aug, 20-22, 2025
SWISS Grand Hotel Convention Center, Seoul, Korea
Aug, 20-22, 2025SWISS Grand Hotel Convention Center, Seoul, Korea
Program Session TopicsUpdated on : 4/18/2025
Plenary Lecture I
| Date & Time | August 20, 2025 (Wed) 10:50-11:25 |
|---|---|
| Co-Chairs | Youngsook Son (Kyung Hee University, Korea) and Inbo Han (CHA University School of Medicine, Korea) |
| Inhee Mook-Jung (Seoul National University College of Medicine, Korea) ▶ Modeling the Gut–Brain Axis of Alzheimer’s Disease Through Patient-Derived iPSCs: Mechanisms and Therapeutic Implications |
|
Plenary Lecture II
| Date & Time | August 20, 2025 (Wed) 11:25-12:00 |
|---|---|
| Co-Chairs | Youngsook Son (Kyung Hee University, Korea) and Inbo Han (CHA University School of Medicine, Korea) |
| Masayo Takahashi (Vision Care Inc., Japan) ▶ Strategy for the retinal cell therapy |
|
Plenary Lecture III
| Date & Time | August 20, 2025 (Wed) 13:45-14:20 |
|---|---|
| Co-Chairs | Dong-Wook Kim (Yonsei University College of Medicine, Korea) and Kunyoo Shin (Seoul National University, Korea) |
| In-Hyun Park (Yale University, USA) ▶ Development of regionally defined human forebrain organoids |
|
Session I
| Date & Time | August 20, 2025 (Wed) 9:00-10:20 |
|---|---|
| Skin & Hair | |
| Co-Chairs | Sekyu Choi (POSTCH, Korea) and Inwha Back (Kyung Hee University, Korea) |
|
Hanseul Yang (KAIST, Korea) ▶ Made to be broken: A novel fracture lattice in spiny mouse skin facilitates tissue autotomy and regeneration |
|
|
Jungwoon Lee (KRIBB. Korea) ▶ Pluripotent Stem Cell-Derived Epidermal Organoids as a Platform for Skin Regeneration and Disease Modeling |
|
|
Chang Hun Huh (Seoul National University Bundang Hospital, Korea) ▶ Stem Cell Therapy: Present Challenges and Future Opportunities |
|
Session II
| Date & Time | August 20, 2025 (Wed) 14:20-15:40 |
|---|---|
| Sensory Organs | |
| Co-Chairs | Han Su Kim (Ewha Women's University, Korea) and Hun Lee (Asan Medical Center, Korea) |
|
Jin Woo Kim (KAIST, Korea) ▶ Restoration of retinal regenerative potential of Müller glia in mammalian retina |
|
|
Dong Hyun Jo (Seoul National University College of Medicine, Korea) ▶ Induced Pluripotent Stem Cells as a Translational Platform for Inherited Retinal Diseases |
|
|
Sang Jin Kim (Samsung Medical Center, Korea) ▶ Development of gene therapy for inherited retinal degeneration |
|
Session III
| Date & Time | August 20, 2025 (Wed) 16:10-17:30 |
|---|---|
| Brain | |
| Co-Chairs | Seung-Woo Cho (Yonsei University, Korea) and Yoonhee Jin (Yonsei University College of Medicine, Korea) |
|
Chul Hoon Kim (Yonsei University College of Medicine, Korea) ▶ Single-cell transcriptomic analysis of Phelan-McDermid syndrome patient-derived brain organoids |
|
|
Il-Joo Cho (Korea University College of Medicine, Korea) ▶ Advanced Microsystems for Electrophysiological Monitoring of Brain Organoids |
|
|
Sung-Rae Cho (Yonsei University College of Medicine, Korea) ▶ Induction of Endogenous Neurogenesis and Neurorestoration in the Brain |
|
Korean Young Investigators Session
| Date & Time | August 20, 2025 (Wed) 9:00-10:20 |
|---|---|
| Co-Chairs | Man Ryul Lee (Konkuk University, Korea) and Seok-Ho Hong (Kangwon National University, Korea) |
|
Minseong Kim (Sejong University, Korea) ▶ OASIS: CRISPR-Based iPSC Platform for Parkinson's Disease Modeling and Drug Screening |
|
|
Sunkyung Kim (Ajou University School of Medicine, Korea) ▶ C/EBP⍺ activates Irf8 expression in myeloid progenitors at the +56 kb enhancer to initiate cDC1 development |
|
|
Seonghyun Lee (Sungkyunkwan University, Korea) ▶ Precise mitochondrial DNA editing via engineered, high-fidelity cytosine and adenine base editors |
|
|
Yeri Alice Rim (The Catholic University of Korea, Korea) ▶ Clinical-Grade iPSC-Derived Chondrogenic Micropellets for Treating Advanced Cartilage Defects |
|
|
Jumee Kim (Sookmyung Women's University, Korea) ▶ Achieving intestinal regeneration without injury through in vivo partial reprogramming |
|
|
Taewan Kim (DGIST, Korea) ▶ Human Stem Cell-based Cell Replacement Therapy to Parkinson’s Disease |
|
ABC-Based Regenerative Bio Therapeutics
| Date & Time | August 20, 2025 (Wed) 14:20-15:40 |
|---|---|
| Co-Chairs | Jihwan Song (CHA University, Korea) and Ssang-Goo Cho (Konkuk University, Korea) |
|
Janghwan Kim (KRIBB, Korea) ▶ Activated Blastema Cells: novel resource for developing regenerative therapeutics |
|
|
Hyuk-Jin Cha (Seoul National University, Korea) ▶ Partial In vivo reprogramming for tissue regeneration |
|
|
Jongpil Kim (Dongguk University, Korea) ▶ Alleviation of Aging-Related Hallmarks in a Mouse Model of Progeria via a Nanoparticle-Based Artificial Transcription Factor |
|
|
Soo Han Bae Yonsei University College of Medicine, Korea) ▶ Application of artificial blastema cell (ABC)-mediated regenerative medicine for metabolic dysfunction-associated steatohepatitis (MASH) |
|
|
Il-Hoan Oh (The Catholic University of Korea, Korea) ▶ Molecular Platforms for “in-vivo reprogramming” therapy |
|
IJSC 2024 Highlight Session
| Date & Time | August 20, 2025 (Wed) 16:10-17:30 |
|---|---|
| Co-Chairs | Chang-Hwan Park (Korea Health Industry Development Institute, Korea) and Dong-Myung Shin (University of Ulsan College of Medicine, Korea) |
|
Woong Sun (Korea University, Korea) ▶ Unraveling Developmental Neurotoxicity of Valproic Acid in Neural Organoid Models |
|
|
Kyung-Sun Kang (Seoul National University, Korea) ▶ Generation of tissue specific assembloid based on blood vessel organoids |
|
|
Yong Jun Kim (Kyung Hee University, Korea) ▶ Epitranscriptomic control maintains viability of human pluripotent stem cells through m6A modification |
|
Plenary Lecture IV
| Date & Time | August 21, 2025 (Thu) 10:50-11:25 |
|---|---|
| Co-Chairs | Hye Ryoun Jang (Sungkyunkwan University School of Medicine, Korea) and Yee Sook Cho (KRIBB, Korea) |
|
Joseph Wu (Stanford University Cardiovascular Institute, USA) ▶ Stem Cells, Genomics, and AI for Drug Discovery |
|
Plenary Lecture V
| Date & Time | August 21, 2025 (Thu) 11:25-12:00 |
|---|---|
| Co-Chairs | Hye Ryoun Jang (Sungkyunkwan University School of Medicine, Korea) and Yee Sook Cho (KRIBB, Korea) |
|
Sean M Wu (Stanford University School of Medicine, USA) ▶ Application of AI in Stem Cell Cardiac Differentiation and Disease Modeling |
|
AASCRM Leadership Session
| Date & Time | August 21, 2025 (Thu) 13:00-14:20 |
|---|---|
| Co-Chairs | Jihwan Song (CHA University, Korea) and Yun Sil Chang (Sungkyunkwan University School of Medicine, Korea) |
|
Shigeru Miyagawa (JSRM, Japan) ▶ The current situation and future of the Japanese Society for Regenerative Medicine |
|
|
Baoyang Hu (CSSCR, China) ▶ Bridging Borders in Regenerative Medicine: CSSCR as China’s Global Collaborative Hub |
|
|
Jonathan Yuin-Han Loh (SCSS, Singapore) ▶ Rewiring Naive, Primed, and Expanded Pluripotency through Transcription Factor-Transposable Element Interactions |
|
|
Lincon Stamp (ASSCR, Australia) ▶ Stem Cells Down Under: Australia as a hub of stem cell innovation and collaboration |
|
Session IV
| Date & Time | August 21, 2025 (Thu) 9:00-10:20 |
|---|---|
| Heart | |
| Co-Chairs | Hyuk-Jin Cha (Seoul National University, Korea) and Soah Lee (Sungkyunkwan University, Korea) |
|
Chul-Hwan Lee (Seoul National University College of Medicine, Korea) ▶ Epigenetics: Polycomb, Chromatin Architecture and Cardiomyocyte Maturation |
|
|
Mikyung Shin (Sungkyunkwan University, Korea) ▶ Tissue-adhesive hydrogels for sutureless epicardial electronics and localized drug delivery |
|
|
Youngkeun Ahn (Chonnam National University Hospital, Korea) ▶ Reproducible Cardiac Organoid Generation with Improved Structural and Functional Maturation |
|
Session V
| Date & Time | August 21, 2025 (Thu) 14:20-15:40 |
|---|---|
| Lung | |
| Co-Chairs | Jeong-Kee Yoon (Chung-Ang University, Korea) and Young-Jae Cho (Seoul National University Bundang Hospital, Korea) |
|
Jinwook Choi (GIST, Korea) ▶ Inflammation and Stem cell plasticity for lung tissue regeneration and disease |
|
|
Sungjune Jung (POSTECH, Korea) ▶ Bioprinted Lung Models for Drug Efficacy and Toxicity Testing |
|
|
Se-Ran Yang (Kangwon National University, Korea) ▶ Alveolar progenitor cell-targeted therapeutic mechanisms for respiratory pathologies |
|
Session VI
| Date & Time | August 21, 2025 (Thu) 16:10-17:30 |
|---|---|
| Liver & Gut | |
| Co-Chairs | Hyung-Sik Kim (Pusan National University, Korea) and Yohan Kim (Sungkyunkwan University, Korea) |
|
Myung Jin Son (KRIBB, Korea) ▶ Liver Organoids with Hepatobiliary Structures: A Novel Platform for Human Liver Disease Modeling and Toxicity Assessment |
|
|
Jee-Heon Jeong (Sungkyunkwan University, Korea) ▶ Bioengineered MSC Therapy for Inflammatory Bowel Disease |
|
|
Hee Seung Lee (Yonsei University College of Medicine, Korea) ▶ Therapeutic Applications of Patient-Derived Organoids in GI Cancer Management |
|
AASCRM Stem Cell Scientists Session
| Date & Time | August 21, 2025 (Thu) 09:00-10:20 |
|---|---|
| Co-Chairs | Bonkyoung Koo (IBS, Korea) and Jihoon Kim (The Catholic University of Korea, Korea) |
|
Akitsu Hotta (JSRM, Japan) ▶ Genome editing therapy for muscular dystrophies: stem cell and delivery technologies |
|
|
Qi Gu (CSSCR, China) ▶ Macroscopic Tissue Fabrication and Microscopic Cell Migration |
|
|
Adrian Kee Keong Teo (SCSS, Singapore) ▶ Genetic control of insulin secretion by HNF4A and HNF1A transcription factors |
|
|
Jaecheol Lee (KSSCR, Korea) ▶ Human iPSC-Based Disease Models: From Mechanistic Insights to Predictive Platforms |
|
Recent Updates in Translational Stem Cell Science: From Mechanistic Studies to Clinical Trials
| Date & Time | August 21, 2025 (Thu) 14:20-15:40 |
|---|---|
| Co-Chairs | Eek-hoon Jho (University of Seoul, Korea) and Dae-Sung Kim (Korea University, Korea) |
|
Jae Jin Cho (Seoul National University, Korea) ▶ Therapeutic Organoid Tissue Module and its Clinical Trials for Skin regeneration |
|
|
Inkyung Jung (KAIST, Korea) ▶ Decoding Gene Regulatory Programs of Astrocyte Development |
|
|
Jong-Chan Park (Sungkyunkwan University, Korea) ▶Microglial APOE Modulates Alzheimer’s Disease Pathogenesis: Insights from iPSC-Derived 2D/3D Models |
|
Government R&D Session
| Date & Time | August 21, 2025 (Thu) 14:20-15:40 |
|---|---|
| Co-Chairs | Inho Jo (KFRM, Korea) and So Ra Park (RMAF, Korea) |
|
Seongho Ryu (Soonchunhyang University, Korea) ▶ National Policies and Investment Directions for Biomedical R&D |
|
|
Sun-Gill Jung (Ministry of Health and Welfare, Korea) ▶ The Current State and Goals of Regenerative Medicine Policy in Korea |
|
|
Chang-Hwan Park (Korea Health Industry Development Institute, Korea) ▶ Current Status and Future Prospects of National Research Funding Investment in Gene Therapy R&D in Healthcare |
|
|
Hyung Chul Kim (Korea Planning & Evaluation Institute of Industrial Technology, Korea) ▶ Current Advanced Biopharmaceutical Support Policy by MOTIE |
|
|
MinYoung Kim (CHA University School of Medicine, Korea) ▶ Supporting the Development of Advanced Regenerative Medicine Technology for Rare Diseases Based on Patient Demand |
|
Plenary Lecture VI
| Date & Time | August 22, 2025 (Fri) 10:50-11:25 |
|---|---|
| Co-Chairs | Dong Ik Kim (Sungkyunkwan University, Korea) and Seungkwon You (Korea University, Korea) |
|
Jason A. Burdick (University of Colorado Boulder, USA) ▶ Biomaterials and Additive Manufacturing to Guide Stem Cell Behavior |
|
Plenary Lecture VII
| Date & Time | August 22, 2025 (Fri) 11:25-12:00 |
|---|---|
| Co-Chairs | Dong Ik Kim (Sungkyunkwan University, Korea) and Seungkwon You (Korea University, Korea) |
|
Anne Grapin-Botton (Max Planck Institute of Molecular Cell Biology and Genetics, Germany) ▶ Engineering pancreas organoids to study pancreas development and disease |
|
Plenary Lecture VIII
| Date & Time | August 22, 2025 (Fri) 13:25-14:20 |
|---|---|
| Co-Chairs | Dongho Choi (Hanyang University, Korea) and Jeong Tae Do (Konkuk University, Korea) |
|
Keith Alm (ISSCR, USA) ▶ ISSCR | Overview, Updates, and Opportunities for Collaboration |
|
|
Jack T. Mosher (ISSCR, USA) ▶ THE ISSCR STANDARDS INITIATIVE: INCREASING RIGOR AND ADVANCING TRANSLATION |
|
Session VII
| Date & Time | August 22, 2025 (Fri) 9:00-10:20 |
|---|---|
| Muscle | |
| Co-Chairs | Yong Jun Kim (Kyung Hee University, Korea) and Chul-Hwan Lee (Seoul National University College of Medicine, Korea) |
|
Jong-Sun Kang (Sungkyunkwan University School of Medicine, Korea) ▶ Decoding Muscle Stem Cell Aging: Mechanisms and Pathways to Resilience |
|
|
Murim Choi (Seoul National University College of Medicine, Korea) ▶ Inhibiting EZH2 complements steroid effects in Duchenne muscular dystrophy |
|
|
Dong-Hwee Kim (Korea University, Korea) ▶ Engineering the materials-subcellualr interfaces for Medical Biotechnology |
|
Session VIII
| Date & Time | August 22, 2025 (Fri) 14:20-15:40 |
|---|---|
| Bone & Cartilage | |
| Co-Chairs | Hyuk-Soo Han (Seoul National University, Korea) and Taehyung Kim (Sungkyunkwan University, Korea) |
|
Hwan D. Kim (Korea National University of Transportation, Korea) ▶ Engineering Stem Cell Spheroids: The Impact of Endothelial Cell Localization on Vascularization and Differentiation |
|
|
Hyun-Do Jung (Hanyang University, Korea) ▶ NIR-Responsive 3D-Printed Scaffolds for Theragenerative Applications |
|
|
Jin Kyu Lee (Hanyang University College of Medicine, Korea) ▶ Development of a Novel MSC Implantation Procedure for Anterior Cruciate Ligament Reconstruction |
|
Session IX
| Date & Time | August 22, 2025 (Fri) 16:10-17:30 |
|---|---|
| Blood | |
| Co-Chairs | Eun Jung Baek (Hanyang University, Korea) and Jeong Ho-Chang (Sungkyunkwan University School of Medicine, Korea) |
|
Kyung-Rok Yu (Seoul National University, Korea) ▶ Humanized Mouse Models in Hematopoietic Research: From Disease Mechanisms to Therapeutics |
|
|
Seongjun Park (Seoul National University, Korea) ▶ Biomedical Interfaces for Neuroscience and Tissue Engineering |
|
|
Youngil Koh (Seoul National University College of Medicine, Korea) ▶ Role of clonal hematopoiesis in human disease |
|
Stem Cell R&D: Past, Present, and Future
| Date & Time | August 22, 2025 (Fri) 9:00-10:20 |
|---|---|
| Chair | Woong Sun (Korea University, Korea) |
|
Moo Woong Kim (KRIBB, Korea) ▶ Stem Cell R&D Landscape and Our Strategic Direction |
|
|
Jeong Tae Do (Konkuk University, Korea) ▶ Fundamental Stem Cell Research: Past Achievements, Present Challenges, and Future Directions |
|
|
YunSil Chang (Sungkyunkwan University School of Medicine, Korea) ▶ Stem Cell Research and Therapy in Korea: Yesterday's Challenges and Today's Progress from a Clinician's Perspective |
|
|
Panel discussion ▶ The Potential and Future of Stem Cells |
|
MFDS Session
| Date & Time | August 22, 2025 (Fri) 14:20-15:40 |
|---|---|
| Chair | TBD |
|
Yusuke Nozaki (Ministry of Food and Drug Safety, Japan) ▶ Current Status on Cell and Gene Therapy in Japan |
|
|
Sun Hee Kim (Ministry of Food and Drug Safety, Korea) ▶ Regulatory science in advanced biopharmaceutical research |
|
|
Jongman Yoo (ORGANOIDSCIENCES LTD., Korea) ▶ From Bench to Bedside: Organoid Therapies for Regenerative Medicine Under Korean Regulations |
|
|
Jin Wook Kang (Ministry of Food and Drug Safety, Korea) ▶ Cell Therapy products in South Korea: Considerations from a Quality Control Perspective |
|
Industry Session
| Date & Time | August 22, 2025 (Fri) 16:10-17:30 |
|---|---|
| Co-Chairs | Jintae Kim (Thermo Fisher Scientific, Korea) and Antonio Lee (MEDIPOST Co., Ltd., Korea) |
|
Jongsoo Woo (STEMCELL Technologies, Korea) ▶ eTeSRTM : Enhanced Maintenance Medium Optimized for Single-Cell Passaging |
|
|
Chaewook Lim (1st PhileKorea. Inc, Korea) ▶ CelVivo Clinostar: A Clinostat-Based System for Stress-Free 3D Cell Culture |
|
|
Sumin Lee (Tomocube, Korea) ▶ To label, or not to label: Label-free 3D imaging and quantitative analysis of live stem cells and organoids using HT-X1 Plus holotomography |
|
|
Spencer Chiang (ACROBiosystems, USA) ▶ Leveraging Laminins to Enhance iPSC-related Cell Therapy Manufacturing Efficiency and Quality | |
|
Seung Han Ryoo (CellSafe Co., Ltd, Korea) ▶ Strategies for Managing Mycoplasma Contamination in Cell Culture and Cell Therapy | |
|
Masaki Hosoya (SINFONIA TECHNOLOGY, Japan) ▶ Realization of QbD approach in cell manufacturing by full-automatization and process analysis |
|